FORT LAUDERDALE, FL - January 27, 2026 - PRESSADVANTAGE - An educational resource published by Grace Point Treatment ...
FORT LAUDERDALE, FL - January 22, 2026 - PRESSADVANTAGE - Grace Point Treatment Center has released an educational ...
Optune Pax® with the chemotherapy combination of gemcitabine and nab-paclitaxel is the first treatment to be FDA approved in nearly 30 years for locally advanced pancreatic cancer.
World Cancer Day collaboration supports clearer, more inclusive access to cancer clinical trials By hosting the ...
Continued treatment with Briumvi provided sustained clinical benefits to patients with relapsing MS, particularly when ...
Updated NCCN pediatric STS guidelines emphasize risk stratification, imaging, multimodal therapy, and clinical trial enrollment to improve outcomes. The National Comprehensive Cancer Network (NCCN) ...
An expert discusses treatment strategies for immune thrombocytopenic purpura (ITP), emphasizing individualized decisions based on platelet count, bleeding symptoms, and comorbidities, with options ...
2d
Pulse Biosciences targets CE Mark submission in 2026 as nPulse platform advances clinical milestones
Q4 2025 earnings call: nsPFA clinical/regulatory timeline, Vybrance rollout, revenue trends, cash burn & outlook—read now.
Asana Recovery outlines its integrated outpatient approach to dual diagnosis treatment in Orange County, addressing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results